A Relative Bioavailability and Food Effect Study of New Formulations

Clinical trial NCT01398475 · COMPLETED

Trial details

NCT number: NCT01398475
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Inflammatory Disorder Arthritis, Rheumatoid

Start date: 2011-07-01
Primary completion: 2011-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.